Rare Disease; Rarer Organization: How EB Research Partnership Drives Rare Disease Research
In this episode of OnAir: Health Care, senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Michael Hund of EB Research Partnership.
Among the topics:
- The severe challenges of the disease EB, or epidermolysis bullosa.
- The venture philanthropy model of funding research into rare diseases.
- Leading technologies in treating EB and other genetic diseases.
- Research fundraising via the federal government.
Subscribe to OnAir Health Care with Akin via iTunes, SoundCloud, YouTube, Spotify and Google Podcasts.
Attachments
Speakers
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.